C. Dubois

Most-cited papers

1. TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer.

   B. Salaun, L. Zitvogel, C. Asselin‐Paturel, Y. Morel +12 more

   2011Cancer Research132 citations Open access

   Semantic Scholar

   Save

2. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

   Perrine J. Martin, C. Dubois, Emilie Jacquier, S. Dion +19 more

   2014Gut98 citations Open access

   Semantic Scholar

   Save

3. Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models

   K. Lélu, C. Dubois, A. Evlachev, Morgane Crausaz +11 more

   2022Journal of Immunology15 citations

   Semantic Scholar

   Save

4. Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models.

   Houda Boukhebza, C. Dubois, Véronique Koerper, A. Evlachev +6 more

   2014Vaccine5 citations

   Semantic Scholar

   Save

5. Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count

   Charles‐Antoine Coupet, C. Dubois, A. Evlachev, Nadine Kehrer +5 more

   2022Human Vaccines & Immunotherapeutics4 citations Open access

   Semantic Scholar

   Save

6. 130 A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE AND HBV TOLERANT MICE

   Perrine J. Martin, C. Dubois, Emilie Jacquier, A. Evlachev +13 more

   20134 citations Open access

   Semantic Scholar

   Save

7. O031 : TG1050, a novel immunotherapeutic to treat chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models

   K. Lélu, A. Evlachev, R. Kratzer, S. Dion +15 more

   20152 citations

   Semantic Scholar

   Save

8. Adaptive Immunity and Confers Survival in Immunotherapy Stimulating Innate and Viral Delivery of IL-7 Is a Potent

   Inchauspé, Leung-Theung-Long, J. Unsinger, Perrine J. Martin +13 more

   20220 citations

   Semantic Scholar

   Save

9. TG1050, a novel immunotherapeutic for the treatment of chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models

   K. Lélu, A. Evlachev, R. Kratzer, O. Godon +16 more

   20150 citations

   Semantic Scholar

   Save

10. 391 PRE-CLINICAL PROOF-OF-CONCEPT STUDIES EXPLORING SCHEDULES OF ADMINISTRATION OF AN ADENOVIRUS- BASED HBV IMMUNOTHERAPEUTIC SHOW WIDE POTENTIAL FOR INDUCTION OF ROBUST AND LONG-LASTING T-CELL RESPONSES

    Houda Boukhebza, C. Dubois, Y. Schlesinger, Véronique Koerper +7 more

    20130 citations

    Semantic Scholar

    Save

11. 449 TOWARDS THE DEVELOPMENT OF A THERAPEUTIC VACCINE TO TREAT CHRONIC HBV INFECTION: AD5-BASED VACCINES ENCODING MULTIPLE HBV ANTIGENS INDUCE STRONG T-CELL RESPONSES IN PRE-CLINICAL MODELS

    Perrine J. Martin, A. Evlachev, D. Olivier, C. Bény +10 more

    20120 citations

    Semantic Scholar

    Save

12. Double-stranded RNA in Breast Cancer TLR 3 as a Biomarker for the Therapeutic Efficacy of

    B. Salaun, L. Zitvogel, C. Asselin‐Paturel, Y. Morel +12 more

    20110 citations

    Semantic Scholar

    Save

13. 35 TLR3 expressed by melanoma cells contributes to double-stranded RNA anti-tumoral effects in vivo

    Salaun Bruno, C. Asselin‐Paturel, Y. Morel, C. Dubois +4 more

    20100 citations

    Semantic Scholar

    Save